Vladimir Semiglazov

3PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersCancer diagnosisTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 23, 2024
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer.

Matteo Dugo, Chiun-Sheng Huang, Daniel Egle

|Jun 17, 2024
[Tumor infiltrating lymphocytes (TILs) in triple negative breast cancer].

Sh R Abdullaeva, T Yu Semiglazova, A S Artemyeva

Pageof 1